Home » Stocks » JUPW

Jupiter Wellness, Inc. (JUPW)

Stock Price: $2.08 USD -0.01 (-0.48%)
Updated Jul 29, 2021 12:41 PM EDT - Market open
Market Cap 22.02M
Revenue (ttm) 996,784
Net Income (ttm) -8.00M
Shares Out 11.41M
EPS (ttm) -0.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $2.08
Previous Close $2.09
Change ($) -0.01
Change (%) -0.48%
Day's Open 2.05
Day's Range 2.04 - 2.11
Day's Volume 672,789
52-Week Range 1.84 - 8.88

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW). Abou...

2 days ago - Accesswire

JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

3 days ago - Accesswire

JUPITER, FL / ACCESSWIRE / July 21, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the pricing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

1 week ago - Accesswire

JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter W...

1 week ago - Accesswire

JUPITER, FL / ACCESSWIRE / July 15, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board. Dr. Andy Goren has more than twen...

2 weeks ago - Accesswire

JUPITER, FL / ACCESSWIRE / July 13, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of pa...

2 weeks ago - Accesswire

*Photo-Therapy in a tub JUPITER, FL / ACCESSWIRE / July 9, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced they have entered into an exclusive agreement to license Photocilâ„¢, a novel patent...

2 weeks ago - Accesswire

https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the sa...

1 month ago - Accesswire

JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact Dermatit...

1 month ago - Accesswire

Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellnes...

3 months ago - Accesswire

Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited) JUPITER, FL / ACCESSWIRE / April 20, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a lea...

3 months ago - Accesswire

JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has appoin...

3 months ago - Accesswire

JUPITER, FL / ACCESSWIRE / March 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herp...

4 months ago - Accesswire

Ecommerce site is expanded and optimized for Company's growing portfolio of CBD wellness products JUPITER, FL / ACCESSWIRE / March 2, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuti...

4 months ago - Accesswire

Data Expected Q1 2021 From Study of 66 Patients JUPITER, FL / ACCESSWIRE / December 22, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics a...

7 months ago - Accesswire

About JUPW

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the ... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Oct 30, 2020
Stock Exchange
NASDAQ
Ticker Symbol
JUPW
Full Company Profile

Financial Performance

In 2020, JUPW's revenue was $1.07 million, an increase of 16,409.14% compared to the previous year's $6,455. Losses were -$6.29 million, 579.6% more than in 2019.

Financial Statements